The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Merus B.V.
Betta Pharmaceuticals Co., Ltd.
Perspective Therapeutics
Second Life Therapeutics
Eli Lilly and Company
National Institutes of Health Clinical Center (CC)
Inhibrx Biosciences, Inc
VM Oncology, LLC
Takeda
BicycleTx Limited
Eli Lilly and Company
ITM Oncologics GmbH
Maastricht University Medical Center
LigaChem Biosciences, Inc.
Bolt Biotherapeutics, Inc.
Palleon Pharmaceuticals, Inc.
Incyte Corporation
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Cancer Research UK
Hoffmann-La Roche
Rapa Therapeutics LLC
Intensity Therapeutics, Inc.
PureTech
Cyteir Therapeutics, Inc.
Aminex Therapeutics, Inc.
NextCure, Inc.
Jacobio Pharmaceuticals Co., Ltd.
SCG Cell Therapy Pte. Ltd.
Second Affiliated Hospital of Guangzhou Medical University
GeneMedicine Co., Ltd.
CytomX Therapeutics
Dana-Farber Cancer Institute
Klus Pharma Inc.
Kineta Inc.
Incyte Corporation
Petra Pharma
Brown University
Memorial Sloan Kettering Cancer Center
Centocor, Inc.
Memorial Sloan Kettering Cancer Center
Siemens Molecular Imaging
National Institutes of Health Clinical Center (CC)
Medical University Innsbruck